Suppr超能文献

衰老、端粒与心力衰竭。

Aging, telomeres and heart failure.

机构信息

Division of Experimental Cardiology, Department of Cardiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.

出版信息

Heart Fail Rev. 2010 Sep;15(5):479-86. doi: 10.1007/s10741-010-9173-7.

Abstract

During normal aging, the heart undergoes functional, morphological and cellular changes. Although aging per se does not lead to the expression of heart failure, it is likely that age-associated changes lower the threshold for the manifestation of signs and symptoms of heart failure. In patients, the susceptibility, age of onset and pace of progression of heart failure are highly variable. The presence of conventional risk factors cannot completely explain this variability. Accumulation of DNA damage and telomere attrition results in an increase in cellular senescence and apoptosis, resulting in a decrease in the number and function of cells, contributing to the overall tissue and organ dysfunction. Biological aging, characterized by reduced telomere length, provides an explanation for the highly interindividual variable threshold to express the clinical syndrome of heart failure at some stage during life. In this review, we will elaborate on the current knowledge of aging of the heart, telomere biology and its potential role in the development of heart failure.

摘要

在正常衰老过程中,心脏会发生功能、形态和细胞变化。尽管衰老本身不会导致心力衰竭的表现,但与年龄相关的变化可能会降低心力衰竭的体征和症状表现的阈值。在患者中,心力衰竭的易感性、发病年龄和进展速度差异很大。传统危险因素的存在并不能完全解释这种可变性。DNA 损伤和端粒磨损的积累导致细胞衰老和细胞凋亡增加,从而导致细胞数量和功能减少,导致整体组织和器官功能障碍。以端粒长度缩短为特征的生物学衰老,为在生命的某个阶段表达心力衰竭的临床综合征的个体间差异很大的阈值提供了一种解释。在这篇综述中,我们将详细阐述心脏衰老、端粒生物学及其在心力衰竭发展中的潜在作用的现有知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e451/2919688/a6b199c79b94/10741_2010_9173_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验